SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs & Pharmaceuticals informs about newspaper publication

23 Oct 2024 Evaluate
Welcure Drugs & Pharmaceuticals has informed that an Advertisement has been published in the Financial Express [English newspaper] and Jan Satta [Hindi Newspaper] on Wednesday, October 23, 2024 intimating about the forfeiture of 1,53,900 partly paid-up Equity Shares of Welcure Drugs & Pharmaceuticals in respect of which, Rs 5.00 each remains unpaid from the concerned shareholders. In this regard it has enclosed newspaper clipping and oblique.

The above information is a part of company’s filings submitted to BSE.

Welcure Drugs&Pharma Share Price

0.32 -0.01 (-3.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×